Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2014 Dec 16:15:12-3.
doi: 10.1016/j.rmcr.2014.11.006. eCollection 2015.

Co-infection of long-standing extensively drug-resistant Mycobacterium tuberculosis (XDR-TB) and non-tuberculosis mycobacteria: A case report

Affiliations
Case Reports

Co-infection of long-standing extensively drug-resistant Mycobacterium tuberculosis (XDR-TB) and non-tuberculosis mycobacteria: A case report

Nafiseh Izadi et al. Respir Med Case Rep. .

Abstract

We report a 69-years-old Iranian HIV negative male patient, with long-standing pulmonary tuberculosis (eleven years) co-infected with non-tuberculosis mycobacteria. Despite of initiation of first line anti-tuberculosis therapy after diagnosis the patient poorly respond because of low compliance with anti-TB treatment. After several incomplete treatments the smear was still positive and thus drug susceptibility tests were performed on isolated organism which revealed that the organisms was resistant not only against isoniazid and rifampin but also against Ofloxacin (OFX), Capreomycin (CAP), p-aminosalicylic acid (PAS), ethionamide (ETH), Kanamycin (KAN), ciprofloxacin (Cip), amikacin (AMK) and cycloserine (CYC). Persistence and resistance of infection had led us to do more investigation using molecular methods, which revealed co-infection with Non-tuberculosis mycobacteria (NTM). The patient is still alive with cough and shortness of breath.

Keywords: Mycobacterium tuberculosis; NTM; XDR-TB.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Chest radiography showing bilateral infiltration in upper lobes.

Similar articles

Cited by

References

    1. Center for Diseases Control and Prevention Emergence of Mycobacterium tuberculosis with extensive resistance to secondline drugs – worldwide, 2000-2004. MMWR Morb Mortal Wkly Rep. 2006;55:301–305. - PubMed
    1. World Health Organization Case definition for extensively drugresistant tuberculosis. Wkly Epidemiol Rec. 2006;42:408. - PubMed
    1. World Health Organization . 2011. Global tuberculosis control: WHO report.
    1. Loddenkemper R., Hauer B. Drug-resistant tuberculosis: a worldwide epidemic poses a new challenge. Dtsch Arztebl Int. 2010 Jan;107(1–2):10–19. - PMC - PubMed
    1. Hsing S.C., Weng S.F., Cheng K.C., Shieh J.M., Chen C.H., Chiang S.R. Increased risk of pulmonary tuberculosis in patients with previous non-tuberculous mycobacterial disease. Int J Tuberc Lung Dis. 2013 Jul;17(7):928–933. - PubMed

Publication types

LinkOut - more resources